- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 221/04 - Ortho- or peri-condensed ring systems
Patent holdings for IPC class C07D 221/04
Total number of patents in this class: 269
10-year publication summary
24
|
14
|
16
|
17
|
7
|
24
|
19
|
17
|
22
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Tetra Discovery Partners, LLC | 12 |
8 |
Glaxo Group Limited | 4281 |
6 |
Hoffmann-La Roche Inc. | 3267 |
6 |
Genentech, Inc. | 3869 |
6 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 806 |
6 |
SHY Therapeutics LLC | 26 |
6 |
Bristol-myers Squibb Company | 4863 |
5 |
F. Hoffmann-La Roche AG | 7942 |
4 |
Enanta Pharmaceuticals, Inc. | 422 |
4 |
Givaudan SA | 1820 |
4 |
InterMune, Inc. | 95 |
4 |
Jiangsu Hengrui Medicine Co., Ltd. | 760 |
4 |
Nippon Soda Co., Ltd. | 883 |
4 |
Reata Pharmaceuticals, Inc. | 121 |
4 |
Shanghai Hengrui Pharmaceutical Co., Ltd. | 627 |
4 |
Sumitomo Pharma Co., Ltd. | 633 |
4 |
Novartis AG | 11254 |
3 |
Bayer AG | 3209 |
3 |
Bayer Pharma AG | 1085 |
3 |
Vertex Pharmaceuticals Incorporated | 1568 |
3 |
Other owners | 178 |